Breast Cancer Trials
Select Clinical Trial
Protocol Number: NSABP B-61, GO42784
Protocol Title: A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared with Physician's Choice of Adjuvant Endocrine Monotherapy in Patients with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer.
Eligibility: Men or women ages 18 and older, diagnosed with ER positive, HER2 negative breast tumor, stage 1-3. Participants who have received (neo)adjuvant chemotherapy and/or had surgery and had no prior endocrine therapy
Contact Information: (910) 715-2200
____________________________________________________________________________________________
Protocol Number: URCC16070, NCT 03367572
Protocol Title: Treatment of Refractory Nausea
Eligibility: Men or women ages 18 and older, receiving chemotherapy for breast cancer.
Contact Information: (910) 715-2200